Human papilloma virus
Human papillomavirus (HPV) is a group of small, non-enveloped, double-stranded DNA viruses of the family Papillomaviridae, comprising more than 200 genotypes that infect cutaneous and mucosal squamous epithelium.
Human papillomavirus (HPV) is a group of small, non-enveloped, double-stranded DNA viruses of the family Papillomaviridae, comprising more than 200 genotypes that infect cutaneous and mucosal squamous epithelium. Roughly 40 types are transmitted through sexual contact, and genital HPV infection is among the most common sexually transmitted infections worldwide. Most infections are transient and cleared by the host immune response; it is persistent infection with a high-risk type that carries disease risk. Low-risk types such as HPV 6 and 11 cause benign warts, while high-risk types — chiefly HPV 16 and HPV 18 — account for the majority of HPV-attributable Cancers.
HPV replicates in differentiating squamous epithelium, and its oncogenic potential rests on the viral E6 and E7 proteins, which inactivate the tumor suppressors TP53 and retinoblastoma protein and drive unscheduled cell cycle entry and genomic instability. Integration of viral DNA into the host genome, with loss of the E2 regulatory gene, deregulates E6 and E7 expression and contributes to malignant transformation. Persistent high-risk infection is the necessary cause of essentially all cervical Cancer and a substantial share of anal, vulvar, vaginal, penile, and oropharyngeal Cancers, placing HPV alongside oncogenic infections such as hepatitis B virus and Helicobacter pylori as a preventable contributor to the global Cancer burden. Prophylactic HPV vaccine, including quadrivalent and later multivalent formulations, elicits neutralizing antibodies against the L1 capsid protein and prevents incident infection with the targeted types; together with cervical screening based on high-risk HPV DNA detection, it forms the basis of current cervical Cancer prevention. Because vaccine uptake varies widely across countries and populations, much current research addresses real-world effectiveness in adult women, coverage among groups at elevated risk of sexually transmitted infection, and the behavioral and sociocultural determinants of vaccination in low- and middle-income settings.
- Societal and fiscal gains from HPV vaccination in Poland - return on investment from extending access to HPV vaccination. PMID 42717549
Where the papers sit
24 papers study human papilloma virus directly. The themes below are drawn from those 24. 1 new direction follows.
-
HPV Vaccination Policy and Uptake : HPV vaccination work emphasizes broader access, targeted uptake strategies and economic evaluation. Coverage is shaped by consent rules, childhood adversity, sexual-debut concerns and affordability, while real-world protection against high-risk HPV is being measured. 9 papers · 37.5%
-
HPV Cancer Prevention and Surveillance : HPV cancer prevention links post-treatment viral detection and persistence with recurrence, while modeling estimates population cancer reduction from vaccination. Context-specific hesitancy tools, biomarkers and wastewater surveillance extend monitoring across settings. 7 papers · 29.2%
-
Inclusive Vaccine Uptake : Vaccination policy is moving toward life-course catch-up and tailored delivery for migrants and LGBTQIA+ communities. Uptake remains tied to knowledge, social-media information, health-worker communication and hesitancy across HPV and other vaccines. 5 papers · 20.8%
-
HPV Vaccine Acceptance : HPV vaccination decisions are being framed through both economic value and informed acceptance. Cost-effectiveness modeling is paired with measurement of knowledge and willingness among young women, supporting education and prevention strategies beyond vaccine delivery alone. 3 papers · 12.5%
Human papillomavirus becomes a wastewater-surveillance signal rather than only a human infection, vaccine target, cancer association, or antiviral target
The study of oncogenic viruses in wastewater across 16 Texas cities 42126240May detected and tracked HPV-associated viral signals in community wastewater over time. The set otherwise treats HPV through individual infection, vaccination, cancer detection or causation, and direct antiviral intervention; this paper instead gives HPV an environmental epidemiology role as a population-level wastewater marker, opening a direction for monitoring its circulation without sampling individuals.
Recent Findings on human papilloma virus
HPV Vaccination Policy and Uptake: Extending HPV vaccination eligibility and coverage in Poland is projected to reduce HPV-related disease and mortality while producing substantial societal and fiscal returns 42717549Sep. Comparative policy analysis identifies school-based delivery, nursing infrastructure, governance quality, and community trust as major influences on equitable coverage, while single-dose schedules still require country-specific evidence 42670010Aug. Real-world vaccination in Chinese women aged 18–45 provided moderate protection against vaccine-type high-risk HPV DNA positivity, with greater effectiveness at least two years after vaccination 42429434Jul. Uptake studies examine missed vaccination among adolescents and young adults, including links with childhood adversity, school absence, education, minor-consent laws, sexual-debut concerns, and provider recommendation 42167948May42143954May42128504May42105393May42019130Apr. Preclinical work also identifies boronic acid-modified neocryptolepine derivative 13b as an anti-HPV candidate that directly inactivates HPV pseudovirions and inhibits infection in mice 41990616Apr.
HPV Cancer Prevention and Surveillance: Post-treatment serum HPV detection is being investigated as a marker associated with recurrent cervical cancer, while simulation models project the long-term effects of vaccination on cervical and oropharyngeal cancer burden 42347892Jun41905061Mar. Wastewater metagenomics expands surveillance by tracking oncogenic viruses, including HPV, with broad genomic coverage and species- or type-level resolution in some samples 42126240May. Biomarker studies in oesophageal squamous cell carcinoma continue to report heterogeneous HPV prevalence and require prospective validation, whereas TCGA analyses find excellent HPV detection accuracy but context-dependent reliability for downstream associations 42028731Apr42017663Apr. Behavioral surveillance is also becoming more context-specific through culturally and linguistically adapted BeSD-HPV tools in Pakistan and assessments of parental refusal in Morocco 42296125Jun42090367May.
Inclusive Vaccine Uptake: Migrants and LGBTQIA+ populations are becoming explicit targets of life-course and catch-up vaccination strategies, although migrant-inclusive routine vaccination policies remain rare across low-and-middle-income countries 42172819May. Italian LGBTQIA+ respondents showed limited knowledge and low uptake across HPV and other vaccines, while healthcare-worker information was associated with greater knowledge, perceived usefulness, and uptake 42348835Jun. Australian survey work compares selective vaccines such as HPV with universal vaccines among gay, bisexual, transgender, and non-binary people, extending policy analysis across sexually transmitted and non-sexually transmitted infections 42219251May. Digital interventions and social-media analyses suggest that informational milestones can increase online discussion, but online activity rarely produces immediate changes in vaccination rates 42133976May42113956May. The field is therefore moving toward tailored communication, healthcare-worker recommendations, and delivery systems that address social and structural exclusion.
HPV Vaccine Acceptance: Knowledge, willingness, and economic value form the main strands of current HPV vaccine acceptance research. A Chengdu study compares HPV and vaccine knowledge among female healthcare and non-healthcare undergraduates and examines its association with vaccination willingness 42189795May. A Jordanian modelling study evaluates the cost-effectiveness of HPV vaccination for preventing cervical cancer 42070373May. Global cancer-prevention guidance places HPV vaccination alongside screening and treatment of precancerous lesions within strategies to reduce cervical cancer incidence and mortality 42190157May. Together, these studies support prevention strategies that combine informed acceptance with economic evaluation and health-system implementation.
Written from 24 PubMed abstracts, each one cited by PMID above. Published: 2026-07-02. Last written: 2026-09-11 by GPT. Reviewed by a human editor on 2026-07-24. Drafted by language models from published abstracts; not medical advice.